Echocardiographic Identification of Pulmonary Artery Flow Reversal: An Indicator of Adverse Outcomes in Single

Andrew D Spearman1,2, Salil Ginde3,4,5, Benjamin H Goot3,4

  • 1Division of Cardiology, Department of Pediatrics, Medical College of Wisconsin, Children's Wisconsin, Herma Heart Institute, 9000 West Wisconsin Avenue, Milwaukee, WI, 53226, USA. aspearman@mcw.edu.

Pediatric Cardiology
|July 26, 2020
PubMed

Insights

Retrograde pulmonary artery flow in single ventricle heart disease patients after surgery indicates higher risk for adverse outcomes, including longer hospital stays and reduced transplant-free survival. This finding highlights a critical indicator for monitoring patient health post-palliation.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Echocardiography

Background:

  • Single ventricle congenital heart disease (CHD) requires staged surgical palliation, including superior cavopulmonary connection (SCPC) and Fontan procedures.
  • Successful palliation depends on unobstructed pulmonary blood flow and healthy pulmonary vasculature.

Purpose of the Study:

  • To investigate the association between echocardiographic identification of retrograde flow in branch pulmonary arteries (PAs) and adverse outcomes in single ventricle CHD patients.
  • To determine if PA flow reversal is a risk indicator following SCPC and Fontan palliation.

Main Methods:

  • Retrospective chart review of single ventricle CHD patients who underwent SCPC palliation between 1999 and 2019.
  • Patients were categorized into two cohorts: those with PA flow reversal and those with normal anterograde flow, identified via transthoracic echocardiography with color Doppler.
  • Comparison of clinical outcomes including hospital length of stay, transplant-free survival, overall survival, and progression to Fontan palliation.

Main Results:

  • The PA reversal cohort (21 patients) experienced significantly longer hospital stays post-SCPC (p < 0.001) and reduced transplant-free survival (p = 0.032) compared to the non-reversal cohort (539 patients).
  • No significant difference in overall survival was observed between cohorts (p = 0.099).
  • Patients with PA flow reversal were less likely to progress to Fontan palliation (p = 0.005), with no difference in hospital length of stay post-Fontan.

Conclusions:

  • Echocardiographic identification of branch PA flow reversal in single ventricle physiology is a significant high-risk indicator.
  • This finding suggests potential for earlier identification of patients at risk for adverse outcomes following staged palliation.
  • PA flow reversal may impact the feasibility or timing of subsequent palliative stages, such as the Fontan procedure.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
260
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
522
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
232